Brief: Cumberland Pharmaceuticals Receives FDA Approval For Reditrex Product Line
02/12/2019 13:04
Dec 2 (Reuters) - Cumberland Pharmaceuticals Inc CPIX.O :
* CUMBERLAND PHARMACEUTICALS RECEIVES FDA APPROVAL FOR
REDITREX™
PRODUCT LINE
* CUMBERLAND PHARMACEUTICALS - WILL LAUNCH TWO INJECTABLE
METHOTREXATE PRODUCT LINES WITHIN U.S., INTENDED FOR TREATMENT
OF ACTIVE RHEUMATOID ARTHRITIS
Source text for Eikon: ID:nPn5y0Kf2a
Further company coverage: CPIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cumberland Pharmaceuticals
See all newsBrief: Cumberland Pharmaceuticals Announces Assist-Ssc Trial Top-Line Results
Cumberland Pharmaceuticals Q2 loss widens after Apotex transaction
Brief: Cumberland Pharmaceuticals Announces Special Dividend Of $1.50 Per Share
Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDA‑approved brands to Apotex for $100 mln
NASDAQ RESUMED AT 09:38 AM